357 related articles for article (PubMed ID: 20940398)
1. CD4+ T-cell help in the tumor milieu is required for recruitment and cytolytic function of CD8+ T lymphocytes.
Bos R; Sherman LA
Cancer Res; 2010 Nov; 70(21):8368-77. PubMed ID: 20940398
[TBL] [Abstract][Full Text] [Related]
2. Effects of CD4+ and CD8+ T cells in tumor-bearing mice on antibody production.
Shimizu M; Iwaguchi T
Cancer Immunol Immunother; 1994 Apr; 38(4):272-6. PubMed ID: 7909496
[TBL] [Abstract][Full Text] [Related]
3. Molecular, metabolic, and functional CD4 T cell paralysis in the lymph node impedes tumor control.
Guo M; Abd-Rabbo D; Bertol BC; Carew M; Lukhele S; Snell LM; Xu W; Boukhaled GM; Elsaesser H; Halaby MJ; Hirano N; McGaha TL; Brooks DG
Cell Rep; 2023 Sep; 42(9):113047. PubMed ID: 37651234
[TBL] [Abstract][Full Text] [Related]
4. Tumor-specific memory CD8
Liu Q; Ran L; Yue Z; Su X; Wang L; Wen S; Lei S; Yang X; Zhang Y; Hu J; Tang J; Li Z; Hu L; Zhu B; Xu L; Ye L; Huang Q
Cell Mol Immunol; 2023 Apr; 20(4):423-426. PubMed ID: 36859455
[No Abstract] [Full Text] [Related]
5. Cancer immunotherapy based on mutation-specific CD4+ T cells in a patient with epithelial cancer.
Tran E; Turcotte S; Gros A; Robbins PF; Lu YC; Dudley ME; Wunderlich JR; Somerville RP; Hogan K; Hinrichs CS; Parkhurst MR; Yang JC; Rosenberg SA
Science; 2014 May; 344(6184):641-5. PubMed ID: 24812403
[TBL] [Abstract][Full Text] [Related]
6. The role of CD4+ T cell responses in antitumor immunity.
Pardoll DM; Topalian SL
Curr Opin Immunol; 1998 Oct; 10(5):588-94. PubMed ID: 9794842
[TBL] [Abstract][Full Text] [Related]
7. CD4
Borst J; Ahrends T; Bąbała N; Melief CJM; Kastenmüller W
Nat Rev Immunol; 2018 Oct; 18(10):635-647. PubMed ID: 30057419
[TBL] [Abstract][Full Text] [Related]
8. MHC-II neoantigens shape tumour immunity and response to immunotherapy.
Alspach E; Lussier DM; Miceli AP; Kizhvatov I; DuPage M; Luoma AM; Meng W; Lichti CF; Esaulova E; Vomund AN; Runci D; Ward JP; Gubin MM; Medrano RFV; Arthur CD; White JM; Sheehan KCF; Chen A; Wucherpfennig KW; Jacks T; Unanue ER; Artyomov MN; Schreiber RD
Nature; 2019 Oct; 574(7780):696-701. PubMed ID: 31645760
[TBL] [Abstract][Full Text] [Related]
9. CD4⁺ follicular helper T cell infiltration predicts breast cancer survival.
Gu-Trantien C; Loi S; Garaud S; Equeter C; Libin M; de Wind A; Ravoet M; Le Buanec H; Sibille C; Manfouo-Foutsop G; Veys I; Haibe-Kains B; Singhal SK; Michiels S; Rothé F; Salgado R; Duvillier H; Ignatiadis M; Desmedt C; Bron D; Larsimont D; Piccart M; Sotiriou C; Willard-Gallo K
J Clin Invest; 2013 Jul; 123(7):2873-92. PubMed ID: 23778140
[TBL] [Abstract][Full Text] [Related]
10. A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell.
Ridge JP; Di Rosa F; Matzinger P
Nature; 1998 Jun; 393(6684):474-8. PubMed ID: 9624003
[TBL] [Abstract][Full Text] [Related]
11. Induction of a CD8+ cytotoxic T lymphocyte response by cross-priming requires cognate CD4+ T cell help.
Bennett SR; Carbone FR; Karamalis F; Miller JF; Heath WR
J Exp Med; 1997 Jul; 186(1):65-70. PubMed ID: 9206998
[TBL] [Abstract][Full Text] [Related]
12. T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions.
Schoenberger SP; Toes RE; van der Voort EI; Offringa R; Melief CJ
Nature; 1998 Jun; 393(6684):480-3. PubMed ID: 9624005
[TBL] [Abstract][Full Text] [Related]
13. Specific T helper cell requirement for optimal induction of cytotoxic T lymphocytes against major histocompatibility complex class II negative tumors.
Ossendorp F; Mengedé E; Camps M; Filius R; Melief CJ
J Exp Med; 1998 Mar; 187(5):693-702. PubMed ID: 9480979
[TBL] [Abstract][Full Text] [Related]
14. Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer.
Rizvi NA; Hellmann MD; Snyder A; Kvistborg P; Makarov V; Havel JJ; Lee W; Yuan J; Wong P; Ho TS; Miller ML; Rekhtman N; Moreira AL; Ibrahim F; Bruggeman C; Gasmi B; Zappasodi R; Maeda Y; Sander C; Garon EB; Merghoub T; Wolchok JD; Schumacher TN; Chan TA
Science; 2015 Apr; 348(6230):124-8. PubMed ID: 25765070
[TBL] [Abstract][Full Text] [Related]
15. PD-1 identifies the patient-specific CD8⁺ tumor-reactive repertoire infiltrating human tumors.
Gros A; Robbins PF; Yao X; Li YF; Turcotte S; Tran E; Wunderlich JR; Mixon A; Farid S; Dudley ME; Hanada K; Almeida JR; Darko S; Douek DC; Yang JC; Rosenberg SA
J Clin Invest; 2014 May; 124(5):2246-59. PubMed ID: 24667641
[TBL] [Abstract][Full Text] [Related]
16. T-helper-1-cell cytokines drive cancer into senescence.
Braumüller H; Wieder T; Brenner E; Aßmann S; Hahn M; Alkhaled M; Schilbach K; Essmann F; Kneilling M; Griessinger C; Ranta F; Ullrich S; Mocikat R; Braungart K; Mehra T; Fehrenbacher B; Berdel J; Niessner H; Meier F; van den Broek M; Häring HU; Handgretinger R; Quintanilla-Martinez L; Fend F; Pesic M; Bauer J; Zender L; Schaller M; Schulze-Osthoff K; Röcken M
Nature; 2013 Feb; 494(7437):361-5. PubMed ID: 23376950
[TBL] [Abstract][Full Text] [Related]
17. The role and regulation of human Th17 cells in tumor immunity.
Ye J; Livergood RS; Peng G
Am J Pathol; 2013 Jan; 182(1):10-20. PubMed ID: 23159950
[TBL] [Abstract][Full Text] [Related]
18. The prognostic significance of B lymphocytes in invasive carcinoma of the breast.
Mahmoud SM; Lee AH; Paish EC; Macmillan RD; Ellis IO; Green AR
Breast Cancer Res Treat; 2012 Apr; 132(2):545-53. PubMed ID: 21671016
[TBL] [Abstract][Full Text] [Related]
19. Inflammation driven by tumour-specific Th1 cells protects against B-cell cancer.
Haabeth OA; Lorvik KB; Hammarström C; Donaldson IM; Haraldsen G; Bogen B; Corthay A
Nat Commun; 2011; 2():240. PubMed ID: 21407206
[TBL] [Abstract][Full Text] [Related]
20. Follicular helper CD4 T cells (TFH).
Crotty S
Annu Rev Immunol; 2011; 29():621-63. PubMed ID: 21314428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
